Ticaflow

Ticagrelor

CARDIOVASCULAR

INDICATION

rnrn

Ticaflow is indicatedrnrn

–        rnTo reduce the rate of cardiovascular death, myocardial infarction,rnand stroke in patients with acute coronary syndrome (ACS) or a history of myocardialrninfarction (MI).

–        rnFor at least the first 12 months following ACS, it is superior tornClopidogrel.

–        rnAlso reduces the rate of stent thrombosis in patients who havernbeen stented for treatment of ACS.rnrn

DOSAGE AND ADMINISTRATION

rnrn

Initiaterntreatment with 180 mg (Ticaflow 90 mg + Ticaflow 90 mg) oral loading dose followingrnan ACS event. Continue treatment with Ticaflow 90 mg tablet twice daily duringrnthe first year after an ACS event. After one year, administer Ticaflow 60 mg tabletrntwice daily. Use Ticaflow with a daily maintenance dose of Aspirin of 75-100rnmg.rnrnOR,rnAS DIRECTED BY PHYSICIAN.

COMPOSITION

“Calibri”,”sans-serif”;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:
Calibri;mso-hansi-theme-font:minor-latin\\\”>Ticaflow 60:“Calibri”,”sans-serif”;mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:
minor-latin\\\”> mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-hansi-theme-font:
minor-latin\\\”>Each film-coated tablet contains Ticagrelor INN 60 mg.

“Calibri”,”sans-serif”;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:
Calibri;mso-hansi-theme-font:minor-latin\\\”>Ticaflow 90“Calibri”,”sans-serif”;mso-ascii-theme-font:minor-latin;mso-hansi-theme-font:
minor-latin\\\”>: mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-hansi-theme-font:
minor-latin\\\”>Each film-coated tablet contains Ticagrelor INN 90 mg.